Revance Therapeutics Stock (NASDAQ: RVNC) stock price, news, charts, stock research, profile.
Open | $5.14 |
Close | - |
Volume / Avg. | 2.82M / 4.69M |
Day Range | $5.14 - $5.44 |
52 Wk Range | 2.30 - 14.24 |
Market Cap | $549.55M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 30 |
Short Interest | 8.33% |
Days to Cover | 1.63 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Revance Therapeutics (NASDAQ:RVNC) through any online brokerage.
Other companies in Revance Therapeutics’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Third Harmonic Bio (NASDAQ:THRD), Zevra Therapeutics (NASDAQ:ZVRA), Theravance Biopharma (NASDAQ:TBPH) and GH Research (NASDAQ:GHRS).
Revance Therapeutics has a consensus price target of $13.20.
The stock price for Revance Therapeutics (NASDAQ: RVNC) is $5.275 last updated September 23, 2024 at 10:18 AM EDT.
There are no upcoming dividends for Revance Therapeutics.
Revance Therapeutics’s Q3 earnings are confirmed for Wednesday, November 6, 2024.
There is no upcoming split for Revance Therapeutics.
Revance Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.